CorMedix Inc. (CRMD)

CorMedix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	40.65	43.64	43.15	53.32	41.91
Short-Term Investments	11.04	32.39	15.64	12.15	4.44
Cash & Short-Term Investments	51.69	76.03	58.79	65.47	46.35
Cash Growth	-32.02%	29.32%	-10.20%	41.24%	63.58%
Receivables	51.65	-	-	0.05	0
Inventory	7.6	2.11	-	0	0.14
Prepaid Expenses	3.39	0.76	0.62	0.77	1.41
Restricted Cash	-	0.08	0.12	0.13	0.19
Other Current Assets	0.24	0.47	0.01	0.05	0.08
Total Current Assets	114.58	79.45	59.55	66.47	48.18
Property, Plant & Equipment	2.32	2.51	2.38	2.37	1.13
Other Intangible Assets	1.84	-	-	-	-
Other Long-Term Assets	0.11	0.1	0.1	0.1	-
Total Assets	118.85	82.06	62.04	68.95	49.31
Accounts Payable	1.72	4.28	2.2	2.21	1.13
Accrued Expenses	29.95	6.97	3.97	3.01	2.92
Current Portion of Leases	0.17	0.15	0.13	0.12	0.11
Other Current Liabilities	2	-	-	-	-
Total Current Liabilities	33.84	11.4	6.31	5.35	4.16
Long-Term Leases	0.35	0.52	0.67	0.8	0.92
Total Liabilities	34.19	11.92	6.98	6.15	5.09
Common Stock	0.06	0.05	0.04	0.04	0.03
Additional Paid-In Capital	424.13	391.69	330.29	308.33	261.54
Retained Earnings	-339.63	-321.7	-275.36	-245.66	-217.45
Comprehensive Income & Other	0.09	0.09	0.08	0.09	0.1
Total Common Equity	84.66	70.14	55.06	62.8	44.22
Shareholders' Equity	84.66	70.14	55.06	62.8	44.22
Total Liabilities & Equity	118.85	82.06	62.04	68.95	49.31
Total Debt	0.52	0.67	0.8	0.92	1.03
Net Cash (Debt)	51.17	75.36	57.99	64.54	45.32
Net Cash Growth	-32.10%	29.96%	-10.15%	42.43%	59.96%
Net Cash Per Share	0.87	1.48	1.44	1.71	1.59
Filing Date Shares Outstanding	65.18	54.98	44.48	38.71	38
Total Common Shares Outstanding	64.41	54.94	42.79	38.06	33.54
Working Capital	80.74	68.05	53.24	61.12	44.02
Book Value Per Share	1.31	1.28	1.29	1.65	1.32
Tangible Book Value	82.81	70.14	55.06	62.8	44.22
Tangible Book Value Per Share	1.29	1.28	1.29	1.65	1.32

Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q